BeautyHealth Q1 net sales $86.3M (+14% YoY), net loss $22.3M, raises FY23 guidance

SkinHealth Systems Inc.

2023-Q1 EPS reported -$0.17 revenue$86,278,000

Net sales $86.3M (+14% YoY); consumables +21% YoY led by Americas +34% and EMEA +35% ex-Russia.
Net loss $22.3M vs net income $31.5M in prior year; adjusted EBITDA loss $0.5M vs +$1.2M.
GAAP gross margin 62.7% (down from 67.5%); adjusted gross margin 70.0% (down from 71.3%).
Company raises FY2023 net sales guidance and reaffirms EBITDA margin and 2025 long-term targets.
Syndeo international launch planned for Q2 2023; China COVID shutdowns affected Jan-Feb but rebound in March.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SkinHealth Systems Inc. reported the first quarter ended March 31, 2023 results: revenue $86.3 million, net income $(22.3) million. Guidance raised.

Period: the first quarter ended March 31, 2023
Revenue: $86.3 million
Net income: $(22.3) million
Guidance: raised
Result: reported results

Exact text from the filing

BeautyHealth Reports First Quarter 2023 Financial Results On strong consumer demand, delivers double-digit net sales growth in line with 2023 plan Raises fiscal 2023 net sales guidance Long Beach, Calif., May 10, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2023. For the quarter, net sales of $86.3 million increased +14% year-over-year, continuing a trend of double-digit quarterly growth. On the momentum, the Company raises 2023 net sales guidance and reaffirms 2023 EBITDA margin and 2025 long-term targets. The quarter was underpinned by continued strong consumer demand for Hydrafacial treatments, with +21% year-over-year consumables net sales growth globally. Of note, consumables net sales grew +34% year-over-year in the Americas and +13% in EMEA. Excluding $1.2 million of Q1 2022 consumables net sales in Russia, growth in EMEA was +35%. In APAC, consumables net sales declin

View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-017025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.